The present invention features methods, devices, and kits for detecting alevel of one or morebiomarkers in a patient with cancer or determining the responsiveness of apatient with cancer to atreatment, such as treatment with an anthracycline. The invention furtherincludes methods of treatinga patient with cancer by administering, e.g., the anthracycline.